What the MASAI Trial Correspondence in The Lancet Actually Says About AI Screening Evidence - The Clinical Trial Vanguard

A new study published in The Lancet examines whether AI can effectively screen for diseases. This matters because AI screening tools are being developed to help doctors detect conditions earlier, but we need solid evidence that they actually work before they're widely used in hospitals.